Pyranopyrazole and pyrazolopyridine immunomodulators for treatment of autoimmune diseases
申请人:The Rockefeller University
公开号:US11312723B2
公开(公告)日:2022-04-26
Pyranoyrazoles and pyrazolopyridines of formula I or formula II are disclosed:
These compounds inhibit Coagulation Factor XIIa in the presence of thrombin and other coagulation factors. They are useful to treat autoimmune diseases.
公开了式 I 或式 II 的吡喃并吡唑和吡唑并吡啶:
这些化合物在凝血酶和其他凝血因子存在的情况下抑制凝血因子 XIIa。它们可用于治疗自身免疫性疾病。
4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDIN-3-AMINE COMPOUNDS AS CBP AND/OR EP300 INHIBITORS
申请人:Genentech, Inc.
公开号:EP3224258B1
公开(公告)日:2019-08-14
PYRANOPYRAZOLE AND PYRAZOLOPYRIDINE IMMUNOMODULATORS FOR TREATMENT OF AUTOIMMUNE DISEASES